Literature DB >> 21641159

Deliberate self-poisoning: factors associated with recurrent self-poisoning.

Sang Hoon Oh1, Kyu Nam Park, Seung Hee Jeong, Han Joon Kim, Christopher C Lee.   

Abstract

OBJECTIVE: To investigate potential risk factors associated with the repetition of deliberate self-poisoning (DSP).
METHODS: Retrospective medical record review of all patients who presented to the emergency department of a tertiary teaching hospital after DSP between January 1, 2000, and December 31, 2009. Repetition of a suicide attempt was determined from reported episodes before the index episode or from 2 visits to the same hospital during the study period. Demographic information, clinical variables, and other variables at the first suicide attempt were investigated for factors associated with repetition of DSP.
RESULTS: Of the 967 patients, 203 (21%) presented with repeated suicide attempts. Patients with repeat suicide attempts differed in sex, occupation, living condition, method of DSP, history of psychiatric treatment, reversibility, and psychiatric diagnosis. In the multivariate regression analysis, the only reliable associated factors for repeat suicide attempt were sex (P = .001), living condition (P < .001), method of DSP (P < .036), and history of psychiatric treatment (P < .001).
CONCLUSION: Early psychological intervention and close observation is required for patients who are female, living without a family, use antidepressants, and have a history of psychiatric treatment. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21641159     DOI: 10.1016/j.ajem.2011.03.015

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  8 in total

1.  Self-poisoning in the acute care medicine 2005-2012.

Authors:  M Sorge; L Weidhase; M Bernhard; A Gries; S Petros
Journal:  Anaesthesist       Date:  2015-06       Impact factor: 1.041

2.  Psychosocial Factors Associated with Suicide Re-attempts in Persons with Chronic Mental Disabilities in Korea.

Authors:  Sun-Jin Jo; Jung-A Ko; Jung-Suk Park; Hyeon Woo Yim; Kyung-Min Lee; Myung-Soo Lee
Journal:  Community Ment Health J       Date:  2016-05-06

3.  Exposure to psychotropic medications prior to overdose: a case-control study.

Authors:  Yasuyuki Okumura; Hisateru Tachimori; Toshihiko Matsumoto; Daisuke Nishi
Journal:  Psychopharmacology (Berl)       Date:  2015-05-12       Impact factor: 4.530

4.  Clinical Characteristics of Pesticide Self-Harm as Associated with Suicide Attempt Repetition Status.

Authors:  Wei-Chen Huang; Tzung-Hai Yen; Long Lin; Chemin Lin; Yeong-Yuh Juang; Bi-Hwa Wang; Shwu-Hua Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2020-07-16       Impact factor: 2.570

5.  Socio-demographic and psychiatric profile of patients hospitalized due to self-poisoning with suicidal intention.

Authors:  Maja Lumpe; Johannes Schurr; Christian Rabe; Armin Ott; Tobias Zellner; Michael Rentrop; Florian Eyer; Stefanie Geith
Journal:  Ann Gen Psychiatry       Date:  2022-06-09       Impact factor: 3.301

6.  Method choice in nonfatal self-harm as a predictor of subsequent episodes of self-harm and suicide: implications for clinical practice.

Authors:  Matthew Miller; Katherine Hempstead; Tuan Nguyen; Catherine Barber; Sarah Rosenberg-Wohl; Deborah Azrael
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

7.  A retrospective descriptive study of the characteristics of deliberate self-poisoning patients with single or repeat presentations to an Australian emergency medicine network in a one year period.

Authors:  Catherine A Martin; Rose Chapman; Asheq Rahman; Andis Graudins
Journal:  BMC Emerg Med       Date:  2014-08-23

8.  Lessons to be learned: identifying high-risk medication and circumstances in patients at risk for suicidal self-poisoning.

Authors:  Stefanie Geith; Christiane Didden; Christian Rabe; Tobias Zellner; Armin Ott; Florian Eyer
Journal:  Int J Ment Health Syst       Date:  2022-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.